EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

AN EXPERIMENTAL STUDY TO EVALUATE THE EFFECT OF SINGLE DOSE OF CLARITHROMYCIN AND GLIBENCLAMIDE COMBINATION IN COMPARISON WITH MONOTHERAPY OF CLARITHROMYCIN AND GLIBENCLAMIDE ON BLOOD GLUCOSE LEVEL IN NEW ZEALAND ALBINO RABBIT.

Rohini Gambre, Akash Khobragade*, Sadiq Patel, Sarita Jaiswar, Kiran Paripelli and Mansi Brid

ABSTRACT

Introduction: Aim of the study is to evaluate the effect of a combination therapy of Clarithromycin and Glibenclamide given orally as single dose on Blood Glucose level (BGL) at different time intervals 1 hour, 2 hour and 4 hour in albino rabbits. Methods: 20 hrs fasting animal‟s blood was collected for baseline investigations. After feeding, the rabbits were given a single oral dose of 2% gum acacia, Clarithromycin, Glibenclamide and combination of Clarithromycin and Glibenclamide to their respective group. Blood collections were done at 1 hour, 2 hour, 4 hour after drug administration. Results: After 20 hrs fasting mean value of BGL in control, Clarithromycin, Glibenclamide and combination of Clarithromycin and Glibenclamide group were 98.62 ± 0.24, 98.40 ± 0.15, 97.73 ± 0.24 and 98.39 ± 0.13 respectively. After 1 hour the mean values of BGL in Control group, Clarithromycin, Glibenclamide and Clarithromycin + Glibenclamide group were 99.20 ± 0.34, 98.22 ± 0.14, 81.72 ± 0.65 and 79.41 ± 0.39 respectively. At 2 hour the mean value of BGL in Control group, Clarithromycin, Glibenclamide and Clarithromycin + Glibenclamide group were 99.59 ± 0.32, 97.64 ± 0.19, 81.58 ± 0.33, and 77.69 ± 0.25 respectively. By the end of 4 hour the mean value of BGL in Control group, Clarithromycin, Glibenclamide and Clarithromycin + Glibenclamide group were 99.77 ± 0.24, 97.39 ± 0.18, 80.66 ± 0.18 and 78.68 ± 0.44 respectively Conclusion: Combination of Clarithromycin & Glibenclamide shows significant decrease in BGL as compared to Clarithromycin and Glibenclamide alone in non-diabetic albino rabbits at different time intervals for single dose for a single day.

Keywords: Diabetes Mellitus, Clarithromycin, Glibenclamide, BGL.

[Full Text Article] [Download Certificate]